Microbiology

BioScreen Testing is the largest and most experienced GMP industrial microbiology facility in the western United States. The company has 19 years of experience in microbiology testing for pharmaceutical, biotechnology and FDA regulated industries. All testing conforms to ISO 9001:2000 and cGMP or GLP standards.

Antimicrobial Preservative Effectiveness Testing USP, BP, JP, EP Antiseptics and antibiotic testing Bacterial Endotoxin Testing USP Bioburden testing Cleanroom validations Cytotoxicity testing USP Fungicidal Activity Growth Promotion Testing USP Microbial Identification (Vitek) Microbial Limit Testing USP, BP, EP, JP Minimum Bactericidal Concentration (MIC) Minimum Inhibitory Concentration (MIC) Mycoplasma Testing PCR FDA culture method EP method Particulate Matter USP Special projects, contract research and development Sterility Testing AAMI and USP guidelines Sterilization validations (gamma, EO, steam and heat) Water testing (USP)

Contract Research

BioScreen invites contract research in both chemistry and microbiology testing fields. The company is experienced with both long term and short term R&D projects which involve GMP or GLP testing. Our clients range from big pharmaceutical to small biotech and medical device companies. Over the last few years many companies have been outsourcing various aspects of research and development projects to laboratories such as ours. Additionally, we are involved not only in the research phase of a number of biotech projects but also with the analytical needs on a turn key basis for new drugs, IND and ANDA projects. For example, we have the capability to provide fast cost effective analytical methods development and validation.
Many biotech and pharmaceutical companies have found that it is expensive and time consuming to increase staff and to add additional analytical capabilities. It makes good business sense to partner with outside laboratories and have them bear the expense should the drug not meet clinical trial expectations. In many cases companies find themselves in the unenviable position of paying for capital equipment invested on a failed drug project and having to lay off personnel. BioScreen contract research allows clients put their investment capital into other areas. Call or e mail us for more information on how we can provide the talent and technical expertise necessary for your project.

For a written price quotation please e-mail us at info@bioscreen.com or call 310-214-0043.